Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial
Identifieur interne : 004114 ( Main/Exploration ); précédent : 004113; suivant : 004115Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial
Auteurs : Stanley N. Caroff [États-Unis] ; Irene Hurford [États-Unis] ; Janice Lybrand [États-Unis] ; E. Cabrina Campbell [États-Unis]Source :
- Neurologic clinics [ 0733-8619 ] ; 2011.
Abstract
Drug-induced movement disorders have dramatically declined with the widespread use of second generation antipsychotics but remain important in clinical practice and for understanding antipsychotic pharmacology. The diagnosis and management of dystonia, parkinsonism, akathisia, catatonia, neuroleptic malignant syndrome and tardive dyskinesia are reviewed in relation to the decreased liability of the second generation antipsychotics contrasted with evidence from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial. Data from the CATIE trial imply that advantages of second generation antipsychotics in significantly reducing extrapyramidal side effects compared with haloperidol may be diminished when compared with modest doses of lower-potency first generation drugs, that the dichotomy between first and second generation drugs may be oversimplified, and that antipsychotics could be conceptualized as a single drug class with a spectrum of risk for movement disorders depending upon receptor binding affinities and individual patient susceptibility.
Url:
DOI: 10.1016/j.ncl.2010.10.002
PubMed: 21172575
PubMed Central: 3018852
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 002121
- to stream Pmc, to step Curation: 002121
- to stream Pmc, to step Checkpoint: 002135
- to stream Ncbi, to step Merge: 003333
- to stream Ncbi, to step Curation: 003333
- to stream Ncbi, to step Checkpoint: 003333
- to stream Main, to step Merge: 004139
- to stream Main, to step Curation: 004114
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial</title><author><name sortKey="Caroff, Stanley N" sort="Caroff, Stanley N" uniqKey="Caroff S" first="Stanley N." last="Caroff">Stanley N. Caroff</name><affiliation wicri:level="2"><nlm:aff id="A1">Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea></affiliation></author><author><name sortKey="Hurford, Irene" sort="Hurford, Irene" uniqKey="Hurford I" first="Irene" last="Hurford">Irene Hurford</name><affiliation wicri:level="2"><nlm:aff id="A2">Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea></affiliation></author><author><name sortKey="Lybrand, Janice" sort="Lybrand, Janice" uniqKey="Lybrand J" first="Janice" last="Lybrand">Janice Lybrand</name><affiliation wicri:level="2"><nlm:aff id="A3">Department of Psychiatry, The Veterans Affairs Medical Center, Philadelphia, Pennsylvania</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Psychiatry, The Veterans Affairs Medical Center, Philadelphia</wicri:cityArea></affiliation></author><author><name sortKey="Campbell, E Cabrina" sort="Campbell, E Cabrina" uniqKey="Campbell E" first="E. Cabrina" last="Campbell">E. Cabrina Campbell</name><affiliation wicri:level="2"><nlm:aff id="A4">Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">21172575</idno><idno type="pmc">3018852</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018852</idno><idno type="RBID">PMC:3018852</idno><idno type="doi">10.1016/j.ncl.2010.10.002</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">002121</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002121</idno><idno type="wicri:Area/Pmc/Curation">002121</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002121</idno><idno type="wicri:Area/Pmc/Checkpoint">002135</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002135</idno><idno type="wicri:Area/Ncbi/Merge">003333</idno><idno type="wicri:Area/Ncbi/Curation">003333</idno><idno type="wicri:Area/Ncbi/Checkpoint">003333</idno><idno type="wicri:doubleKey">0733-8619:2011:Caroff S:movement:disorders:induced</idno><idno type="wicri:Area/Main/Merge">004139</idno><idno type="wicri:Area/Main/Curation">004114</idno><idno type="wicri:Area/Main/Exploration">004114</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial</title><author><name sortKey="Caroff, Stanley N" sort="Caroff, Stanley N" uniqKey="Caroff S" first="Stanley N." last="Caroff">Stanley N. Caroff</name><affiliation wicri:level="2"><nlm:aff id="A1">Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea></affiliation></author><author><name sortKey="Hurford, Irene" sort="Hurford, Irene" uniqKey="Hurford I" first="Irene" last="Hurford">Irene Hurford</name><affiliation wicri:level="2"><nlm:aff id="A2">Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea></affiliation></author><author><name sortKey="Lybrand, Janice" sort="Lybrand, Janice" uniqKey="Lybrand J" first="Janice" last="Lybrand">Janice Lybrand</name><affiliation wicri:level="2"><nlm:aff id="A3">Department of Psychiatry, The Veterans Affairs Medical Center, Philadelphia, Pennsylvania</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Psychiatry, The Veterans Affairs Medical Center, Philadelphia</wicri:cityArea></affiliation></author><author><name sortKey="Campbell, E Cabrina" sort="Campbell, E Cabrina" uniqKey="Campbell E" first="E. Cabrina" last="Campbell">E. Cabrina Campbell</name><affiliation wicri:level="2"><nlm:aff id="A4">Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Department of Psychiatry, The Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia</wicri:cityArea></affiliation></author></analytic><series><title level="j">Neurologic clinics</title><idno type="ISSN">0733-8619</idno><idno type="eISSN">1557-9875</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Synopsis</title><p id="P1">Drug-induced movement disorders have dramatically declined with the widespread use of second generation antipsychotics but remain important in clinical practice and for understanding antipsychotic pharmacology. The diagnosis and management of dystonia, parkinsonism, akathisia, catatonia, neuroleptic malignant syndrome and tardive dyskinesia are reviewed in relation to the decreased liability of the second generation antipsychotics contrasted with evidence from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial. Data from the CATIE trial imply that advantages of second generation antipsychotics in significantly reducing extrapyramidal side effects compared with haloperidol may be diminished when compared with modest doses of lower-potency first generation drugs, that the dichotomy between first and second generation drugs may be oversimplified, and that antipsychotics could be conceptualized as a single drug class with a spectrum of risk for movement disorders depending upon receptor binding affinities and individual patient susceptibility.</p></div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Caroff, Stanley N" sort="Caroff, Stanley N" uniqKey="Caroff S" first="Stanley N." last="Caroff">Stanley N. Caroff</name></region><name sortKey="Campbell, E Cabrina" sort="Campbell, E Cabrina" uniqKey="Campbell E" first="E. Cabrina" last="Campbell">E. Cabrina Campbell</name><name sortKey="Hurford, Irene" sort="Hurford, Irene" uniqKey="Hurford I" first="Irene" last="Hurford">Irene Hurford</name><name sortKey="Lybrand, Janice" sort="Lybrand, Janice" uniqKey="Lybrand J" first="Janice" last="Lybrand">Janice Lybrand</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004114 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004114 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:3018852
|texte= Movement Disorders Induced by Antipsychotic Drugs: Implications of the CATIE Schizophrenia Trial
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21172575" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |